C158H158ClN25O26S6 — CID 158707803
1-(2-chlorophenyl)sulfonyl-3-[(1S)-1-[1-(4-methoxyphenyl)imidazol-2-yl]-2-phenylethyl]urea;1-[(1S)-1-[1-(3,4-dimethoxyphenyl)imidazol-2-yl]-2-phenylethyl]-3-(2-methylphenyl)sulfonylurea;1-[(1S)-1-[1-(4-ethoxyphenyl)imidazol-2-yl]-2-phenylethyl]-3-(2-methylphenyl)sulfonylurea;1-[(1S)-1-[1-(3-methoxyphenyl)imidazol-2-yl]-2-phenylethyl]-3-(2-methylphenyl)sulfonylurea;1-[(1S)-1-[1-(4-methoxyphenyl)imidazol-2-yl]-2-phenylethyl]-3-(2-methylphenyl)sulfonylurea;methyl N-[4-[2-[(1S)-1-[(2-methylphenyl)sulfonylcarbamoylamino]-2-phenylethyl]imidazol-1-yl]phenyl]carbamate (PubChem CID 158707803) has the molecular formula C158H158ClN25O26S6 and a molecular weight of 3051.01 g/mol. Its IUPAC name is 1-(2-chlorophenyl)sulfonyl-3-[(1S)-1-[1-(4-methoxyphenyl)imidazol-2-yl]-2-phenylethyl]urea;1-[(1S)-1-[1-(3,4-dimethoxyphenyl)imidazol-2-yl]-2-phenylethyl]-3-(2-methylphenyl)sulfonylurea;1-[(1S)-1-[1-(4-ethoxyphenyl)imidazol-2-yl]-2-phenylethyl]-3-(2-methylphenyl)sulfonylurea;1-[(1S)-1-[1-(3-methoxyphenyl)imidazol-2-yl]-2-phenylethyl]-3-(2-methylphenyl)sulfonylurea;1-[(1S)-1-[1-(4-methoxyphenyl)imidazol-2-yl]-2-phenylethyl]-3-(2-methylphenyl)sulfonylurea;methyl N-[4-[2-[(1S)-1-[(2-methylphenyl)sulfonylcarbamoylamino]-2-phenylethyl]imidazol-1-yl]phenyl]carbamate.
| Compound Name | 1-(2-chlorophenyl)sulfonyl-3-[(1S)-1-[1-(4-methoxyphenyl)imidazol-2-yl]-2-phenylethyl]urea;1-[(1S)-1-[1-(3,4-dimethoxyphenyl)imidazol-2-yl]-2-phenylethyl]-3-(2-methylphenyl)sulfonylurea;1-[(1S)-1-[1-(4-ethoxyphenyl)imidazol-2-yl]-2-phenylethyl]-3-(2-methylphenyl)sulfonylurea;1-[(1S)-1-[1-(3-methoxyphenyl)imidazol-2-yl]-2-phenylethyl]-3-(2-methylphenyl)sulfonylurea;1-[(1S)-1-[1-(4-methoxyphenyl)imidazol-2-yl]-2-phenylethyl]-3-(2-methylphenyl)sulfonylurea;methyl N-[4-[2-[(1S)-1-[(2-methylphenyl)sulfonylcarbamoylamino]-2-phenylethyl]imidazol-1-yl]phenyl]carbamate |
|---|---|
| PubChem CID | 158707803 |
| Molecular Formula | C158H158ClN25O26S6 |
| Molecular Weight | 3051.01 g/mol |
| Exact Mass | 3047.98 |
| IUPAC Name | 1-(2-chlorophenyl)sulfonyl-3-[(1S)-1-[1-(4-methoxyphenyl)imidazol-2-yl]-2-phenylethyl]urea;1-[(1S)-1-[1-(3,4-dimethoxyphenyl)imidazol-2-yl]-2-phenylethyl]-3-(2-methylphenyl)sulfonylurea;1-[(1S)-1-[1-(4-ethoxyphenyl)imidazol-2-yl]-2-phenylethyl]-3-(2-methylphenyl)sulfonylurea;1-[(1S)-1-[1-(3-methoxyphenyl)imidazol-2-yl]-2-phenylethyl]-3-(2-methylphenyl)sulfonylurea;1-[(1S)-1-[1-(4-methoxyphenyl)imidazol-2-yl]-2-phenylethyl]-3-(2-methylphenyl)sulfonylurea;methyl N-[4-[2-[(1S)-1-[(2-methylphenyl)sulfonylcarbamoylamino]-2-phenylethyl]imidazol-1-yl]phenyl]carbamate |
| SMILES | CCOc1ccc(-n2ccnc2[C@H](Cc2ccccc2)NC(=O)NS(=O)(=O)c2ccccc2C)cc1.COC(=O)Nc1ccc(-n2ccnc2[C@H](Cc2ccccc2)NC(=O)NS(=O)(=O)c2ccccc2C)cc1.COc1ccc(-n2ccnc2[C@H](Cc2ccccc2)NC(=O)NS(=O)(=O)c2ccccc2C)cc1.COc1ccc(-n2ccnc2[C@H](Cc2ccccc2)NC(=O)NS(=O)(=O)c2ccccc2C)cc1OC.COc1ccc(-n2ccnc2[C@H](Cc2ccccc2)NC(=O)NS(=O)(=O)c2ccccc2Cl)cc1.COc1cccc(-n2ccnc2[C@H](Cc2ccccc2)NC(=O)NS(=O)(=O)c2ccccc2C)c1 |
| InChI | InChI=1S/C27H27N5O5S.C27H28N4O5S.C27H28N4O4S.2C26H26N4O4S.C25H23ClN4O4S/c1-19-8-6-7-11-24(19)38(35,36)31-26(33)30-23(18-20-9-4-3-5-10-20)25-28-16-17-32(25)22-14-12-21(13-15-22)29-27(34)37-2;1-19-9-7-8-12-25(19)37(33,34)30-27(32)29-22(17-20-10-5-4-6-11-20)26-28-15-16-31(26)21-13-14-23(35-2)24(18-21)36-3;1-3-35-23-15-13-22(14-16-23)31-18-17-28-26(31)24(19-21-10-5-4-6-11-21)29-27(32)30-36(33,34)25-12-8-7-9-20(25)2;1-19-9-6-7-14-24(19)35(32,33)29-26(31)28-23(17-20-10-4-3-5-11-20)25-27-15-16-30(25)21-12-8-13-22(18-21)34-2;1-19-8-6-7-11-24(19)35(32,33)29-26(31)28-23(18-20-9-4-3-5-10-20)25-27-16-17-30(25)21-12-14-22(34-2)15-13-21;1-34-20-13-11-19(12-14-20)30-16-15-27-24(30)22(17-18-7-3-2-4-8-18)28-25(31)29-35(32,33)23-10-6-5-9-21(23)26/h3-17,23H,18H2,1-2H3,(H,29,34)(H2,30,31,33);4-16,18,22H,17H2,1-3H3,(H2,29,30,32);4-18,24H,3,19H2,1-2H3,(H2,29,30,32);3-16,18,23H,17H2,1-2H3,(H2,28,29,31);3-17,23H,18H2,1-2H3,(H2,28,29,31);2-16,22H,17H2,1H3,(H2,28,29,31)/t23-;22-;24-;2*23-;22-/m000000/s1 |
| InChIKey | IIIKNYZSJJFTDL-JWRWBSCBSA-N |
| XLogP | 25.88 |
| TPSA | 652.25 Ų |
| H-Bond Donors | 13 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 50 |
| Heavy Atoms | 216 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3051.01 |
| LogP ≤ 5 | 25.88 |
| H-Bond Donors ≤ 5 | 13 |
| H-Bond Acceptors ≤ 10 | 38 |